Document is current

Article History

Received: 18 January 2024

Accepted: 21 November 2024

First Online: 28 November 2024

Declarations

:

: The datasets comprised anonymized data from retrospective studies that had been approved by local ethics committees (ethics committee of the board of physicians in Hamburg, Germany; ethics committee of the Canton Zurich, Switzerland ethics committee of the University Hospital Carl Gustav Carus, Dresden, Germany; and ethics committee of the Carl Jena University Hospital, Jena, Germany). All patients had given written informed consent.

: RO, JK, and LS: Employees of jung diagnostics GmbH, a company that received funding from Bristol Myers Squibb to conduct this research. MS: Has served on advisory boards for and received funding for travel or speaker honoraria from Actelion-Janssen, Almirall, Bayer, Biogen, Bristol Myers Squibb, Celgene, Merck, Novartis, Roche, Sanofi-Genzyme, and Teva; received research support from Bayer and Novartis. DS, SB, and MB: Employees and/or shareholders of Bristol Myers Squibb. CGo: Employee of Conradia Hamburg MVZ GmbH and has nothing to disclose. CGa: Received research support from Novartis. SS: Reports compensation for consulting, serving on scientific advisory boards, speaking, or other activities from Biogen, Celgene, Merck, Sanofi, and Teva; currently an employee of Roche, Basel. HHK: Has received travel grants, speaker honoraria, financial research support, and consultancy fees from Bayer, Biogen Idec, Novartis, Siemens, and Teva; served on advisory boards for Biogen, Ixico, and Novartis; received research grants from Novartis. TZ: Has received advisory board fees from Biogen, Bristol Myers Squibb, Merck, Novartis, Roche, Sanofi, and Teva; received speaker fees from Alexion, Almirall, Biogen, and Bristol Myers Squibb.